Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT06066424	TitlePhase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)	Fase Fase 1	Date Added 2023-10-04	Ubicación Texas, United States	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas Cyclophosphamide, Fludarabine Phosphate, Rimiducid, TROP2-CAR-NK Cells	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06185556	TitleCOLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases	Fase Fase 2	Date Added 2023-12-29	Ubicación Países Bajos	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06218914	TitleA Study of NT-112 in HLA-C*08:02-Positive Adult Subjects With Unresectable, Advanced, and/ or Metastatic Solid Tumors Positive for the KRAS G12D Mutation	Fase Fase 1	Date Added 2024-01-23	Ubicación California, United States Kansas, United States Missouri, United States New York, United States Pennsylvania, United States Tennessee, United States Texas, United States Washington, United States Wisconsin, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04853017	TitleELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (AMPLIFY-201)	Fase Fase 1	Date Added 2021-04-21	Ubicación California, United States Colorado, United States Iowa, United States Massachusetts, United States Missouri, United States New York, United States Tennessee, United States Texas, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03990233	TitleEnsayo de BI 765063 en monoterapia y en combinación con BI 754091 en pacientes con tumores sólidos avanzados.	Fase Fase 1	Date Added 2019-06-18	Ubicación Bélgica Francia	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas BI 754091, BI 765063	Etiquetas MSS/ MMRp
NCT ID NCT03412877	TitleAdministración de células T autólogas modificadas genéticamente para expresar receptores de células T reactivos contra neoantígenos en personas con cáncer metastásico	Fase Fase 2	Date Added 2018-01-29	Ubicación Maryland, United States	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas Aldesleukin, Cyclophosphamide, Fludarabine, Individual Patient TCR-Transduced PBL, Pembrolizumab (Keytruda)	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03530397	TitleUn estudio para evaluar MEDI5752 en sujetos con tumores sólidos avanzados	Fase Fase 1	Date Added 2018-05-21	Ubicación Michigan, United States New York, United States North Carolina, United States Rhode Island, United States Tennessee, United States Virginia, United States Australia Francia Italia Corea, República de Países Bajos Portugal España Taiwán	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas Carboplatin, MEDI5752, Pembrolizumab, Pemetrexed, Alimta, Imfinzi, Keytruda, Paraplatin	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03985891	TitleEficacia del JS001 combinado con quimioterapia en pacientes con cáncer de colon localmente avanzado	Fase Fase 1/Fase 2	Date Added 2019-06-14	Ubicación China	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Anti-PD-1 Monoclonal Antibody JS001, Chemotherapy	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03783403	TitleA Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers	Fase Fase 1	Date Added 2018-12-21	Ubicación Alabama, United States Arizona, United States California, United States Colorado, United States Missouri, United States New York, United States North Carolina, United States Oklahoma, United States Oregon, United States Pennsylvania, United States Tennessee, United States Texas, United States Australia Canadá Francia Italia Corea, República de España Reino Unido	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas CC-95251, cetuximab, Rituximab	Etiquetas MSS/ MMRp
NCT ID NCT01061515	TitleBiweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer	Fase Fase 1	Date Added 2010-02-03	Ubicación Missouri, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Bevacizumab, capecitabine, Intraperitoneal Oxaliplatin, Avastin, Eloxatin, Xeloda	Etiquetas MSS/ MMRp

Showing 31 to 40 of 299 entries